Stevanato Group SpA
Open
SectorHealthcare
16.99 -1.56
Overview
Share price change
24h
Min
16.6
Max
17.34
Income | -7.9M 39M |
|---|---|
Sales | -70M 274M |
P/E Sector Avg | 28.186 49.712 |
EPS | 0.13 |
Profit margin | 14.343 |
Employees | 6,010 |
EBITDA | -25M 65M |
Recommendations | Strong Buy |
|---|---|
12 Months Forecast | +29.7% upside |
Next Earnings | 4 Aug 2026 |
|---|
Market Cap | -317M 4.5B |
|---|---|
Previous open | 18.55 |
Previous close | 16.99 |
News Sentiment
By Acuity
13%
87%
16 / 342 Healthcare
Stevanato Group SpA Chart
Past performance is not a reliable indicator of future results.
About Stevanato Group SpA
Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering. Its principal products include containment solutions, drug delivery systems, medical devices, diagnostic, analytical services, visual inspection machines, assembling and packaging machines, and glass forming machines. The company was founded in 1949 and is headquartered in Piombino Dese, Italy. Stevanato Group S.p.A. is a subsidiary of Stevanato Holding S.R.L.
